Origin & tradition
Not traditional as a supplement: carnosine is abundant in muscle and brain and its anti-aging properties were first studied in Russia.
Western tradition · Dipeptide
An endogenous dipeptide that chelates metals, quenches reactive carbonyls, and inhibits protein glycation — key anti-aging mechanisms.
↑ iHerb link is an affiliate link — we may earn a commission at no cost to you.
Not traditional as a supplement: carnosine is abundant in muscle and brain and its anti-aging properties were first studied in Russia.
Key active: L-Carnosine (β-alanyl-L-histidine dipeptide).
Carnosine is a histidyl dipeptide that acts as a non-enzymatic antioxidant, heavy-metal chelator, and anti-glycation agent (reacting with reactive carbonyls before they crosslink proteins). Carnosine levels decline ~60% from youth to old age. Human trials cover exercise fatigue (via beta-alanine precursor), glycemic control, and cognitive aging.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Glycation / AGE formation | Decreases | Minor | C |
| Cognitive function (elderly) | Increases | Minor | C |
| Muscle buffering / exercise capacity — Beta-alanine is more efficient than carnosine for this purpose | Increases | Minor | C |
| Antioxidant activity | Increases | Minor | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
Carnosine is a dipeptide (beta-alanine + histidine) that acts as an intracellular buffer and anti-glycation agent. It is rapidly broken down by carnosinase in blood — sustained release or repeated dosing is important. Beta-alanine supplementation raises muscle carnosine more efficiently.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Mechanistic + small human trials; aging-specific RCTs limited
Carnosine is a histidyl dipeptide that acts as a non-enzymatic antioxidant, heavy-metal chelator, and anti-glycation agent (reacting with reactive carbonyls before they crosslink proteins). Carnosine levels decline ~60% from youth to old age. Human trials cover exercise fatigue (via beta-alanine precursor), glycemic control, and cognitive aging.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-12. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Suppliers
Tell us what you need and we will source suppliers for you.